Hend Talkhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hend Talkhan has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Khalid Orayj
Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia
2 shared publications Ahmed A. Abdelkader
Department of Pharmacy Practice, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt
1 shared publicationAlaa O. Elyousefy
Faculty of Pharmacy, Heliopolis University, Cairo, Egypt
1 shared publication- Altaf Alfifi
College of Pharmacy, King Khalid University, Abha 61413, Saudi Arabia
1 shared publication Amany Mohamed
Faculty of Pharmacy, Heliopolis University, Cairo, Egypt
1 shared publication- Arwa Al Saeed
College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
Lifestyle-associated gut microbiota signatures in colorectal cancer patients: a pilot case–control study
Background and Objectives: Colorectal cancer (CRC) is the third most common cancer in men and the second in women, accounting for 9.4% of cancer-related deaths worldwide in 2020. Increasing evidence highlights the role of gut microbiota in CRC pathogenesis, prognosis, and therapeutic response. Data from Middle Eastern and North African populations remains scarce. This study aimed to analyze gut microbiota profiles in Egyptian patients with CRC and to explore their associations with dietary and lifestyle factors. Material and Methods: A pilot case-control study was conducted, involving patients with CRC and healthy controls. Gut microbiota composition was assessed using 16S rRNA gene sequencing, with analysis of microbial diversity and differential taxonomic abundance at the family and genus levels. Dietary patterns, physical activity, and demographic variables were evaluated for their associations with microbial profiles. Results: CRC patients exhibited greater microbial heterogeneity, with higher Bray–Curtis distances compared to controls. Several taxa, such as Coprococcus_2 , Ruminococcus , Blautia, and Dorea, were abundant in controls and adjacent normal tissues, whereas Lachnospiraceae UCG-010 was increased in CRC samples. Spicy food intake was linked to enrichment of Prevotellaceae and Christensenellaceae R-7 , while processed meat consumption was associated with reduced abundance of Fusicatenibacter. Regular physical activity was associated with increased Akkermansia abundance among CRC patients. Additionally, sex-specific microbial patterns were observed, with Collinsella , Eggerthella , and Prevotella _ 9 more abundant in males. Conclusions: This pilot study identifies clinically relevant, exploratory associations between lifestyle factors and CRC-related microbial signatures in an understudied population. All findings should be considered hypothesis-generating, given the small sample size and cross-sectional design. These results highlight the potential role of modifiable behaviors in microbiome-informed risk stratification. Larger, multi-center studies incorporating multi-omics approaches are warranted to confirm and extend these preliminary observations.
Open AccessLifestyle-associated gut microbiota signatures in colorectal cancer patients: a pilot case–control study
Background and Objectives: Colorectal cancer (CRC) is the third most common cancer in men and the second in women, accounting for 9.4% of cancer-related deaths worldwide in 2020. Increasing evidence highlights the role of gut microbiota in CRC pathogenesis, prognosis, and therapeutic response. Data from Middle Eastern and North African populations remains scarce. This study aimed to analyze gut microbiota profiles in Egyptian patients with CRC and to explore their associations with dietary and lifestyle factors. Material and Methods: A pilot case-control study was conducted, involving patients with CRC and healthy controls. Gut microbiota composition was assessed using 16S rRNA gene sequencing, with analysis of microbial diversity and differential taxonomic abundance at the family and genus levels. Dietary patterns, physical activity, and demographic variables were evaluated for their associations with microbial profiles. Results: CRC patients exhibited greater microbial heterogeneity, with higher Bray–Curtis distances compared to controls. Several taxa, such as Coprococcus_2 , Ruminococcus , Blautia, and Dorea, were abundant in controls and adjacent normal tissues, whereas Lachnospiraceae UCG-010 was increased in CRC samples. Spicy food intake was linked to enrichment of Prevotellaceae and Christensenellaceae R-7 , while processed meat consumption was associated with reduced abundance of Fusicatenibacter. Regular physical activity was associated with increased Akkermansia abundance among CRC patients. Additionally, sex-specific microbial patterns were observed, with Collinsella , Eggerthella , and Prevotella _ 9 more abundant in males. Conclusions: This pilot study identifies clinically relevant, exploratory associations between lifestyle factors and CRC-related microbial signatures in an understudied population. All findings should be considered hypothesis-generating, given the small sample size and cross-sectional design. These results highlight the potential role of modifiable behaviors in microbiome-informed risk stratification. Larger, multi-center studies incorporating multi-omics approaches are warranted to confirm and extend these preliminary observations.
- Open Access
A Cross-Sectional Analysis of Deprescribing Curricular Exposure, Attitudes, and Preparedness Among Undergraduate Pharmacy Students in Saudi Arabia
Objectives: This study aimed to assess pharmacy students’ curricular exposure to deprescribing, their attitudes and preparedness to perform core deprescribing steps, and their understanding of interprofessional roles in the deprescribing process. Methods: A cross-sectional online survey that included undergraduate pharmacy students in their fifth or sixth year of study, who were enrolled in Saudi universities during the academic year 2025/2026. A 43-item self-administered validated questionnaire was used. The independent-samples t-test was used to examine differences in attitudes and preparedness among participants via SPSS 27. Results: In total, 367 students from 23 universities participated in the study; 54.0% were female, and 62.1% were in their fifth year. Familiarity with the term ‘deprescribing’ was reported by 55.3% of participants. Participants demonstrated highly positive attitudes toward the benefits of deprescribing, moderate toward misconceptions, and low toward barriers, with mean percentage scores of 85.08%, 66.50%, and 41.93%, respectively. Participants indicated moderately positive perceptions toward the non-experiential curriculum preparedness to identify and practice deprescribing and self-perception of the ability to perform core deprescribing steps, with mean percentage scores of 70.2% and 77.24%, respectively. Statistically significant differences were observed in the perception of curriculum preparedness by gender (p = 0.038), familiarity with the term deprescribing (p < 0.001), and exposure to deprescribing in the required pharmacy curriculum (p < 0.001). Participants perceived clinical pharmacists as having the greatest role across most stages of the deprescribing process. Conclusions: Undergraduate pharmacy students in Saudi Arabia recognize the value of deprescribing but have limited curricular exposure and moderate perceived preparedness to deprescribe.
Open AccessA Cross-Sectional Analysis of Deprescribing Curricular Exposure, Attitudes, and Preparedness Among Undergraduate Pharmacy Students in Saudi Arabia
Objectives: This study aimed to assess pharmacy students’ curricular exposure to deprescribing, their attitudes and preparedness to perform core deprescribing steps, and their understanding of interprofessional roles in the deprescribing process. Methods: A cross-sectional online survey that included undergraduate pharmacy students in their fifth or sixth year of study, who were enrolled in Saudi universities during the academic year 2025/2026. A 43-item self-administered validated questionnaire was used. The independent-samples t-test was used to examine differences in attitudes and preparedness among participants via SPSS 27. Results: In total, 367 students from 23 universities participated in the study; 54.0% were female, and 62.1% were in their fifth year. Familiarity with the term ‘deprescribing’ was reported by 55.3% of participants. Participants demonstrated highly positive attitudes toward the benefits of deprescribing, moderate toward misconceptions, and low toward barriers, with mean percentage scores of 85.08%, 66.50%, and 41.93%, respectively. Participants indicated moderately positive perceptions toward the non-experiential curriculum preparedness to identify and practice deprescribing and self-perception of the ability to perform core deprescribing steps, with mean percentage scores of 70.2% and 77.24%, respectively. Statistically significant differences were observed in the perception of curriculum preparedness by gender (p = 0.038), familiarity with the term deprescribing (p < 0.001), and exposure to deprescribing in the required pharmacy curriculum (p < 0.001). Participants perceived clinical pharmacists as having the greatest role across most stages of the deprescribing process. Conclusions: Undergraduate pharmacy students in Saudi Arabia recognize the value of deprescribing but have limited curricular exposure and moderate perceived preparedness to deprescribe.
- Open Access
- 1 April 2026
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 20, 1-23
Immunomodulatory and Anti-Inflammatory Effects of Ketotifen Versus Vitamin E in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Pilot Study
Background: Non-alcoholic fatty liver disease (NAFLD) represents a prevalent, long-standing hepatic condition marked by the accumulation of fat in the liver and varying degrees of fibrotic changes. Ketotifen, a mast cell stabilizer, has been proposed to modulate inflammation and fibrogenesis, but clinical evidence is limited. Objective: To assess the effectiveness and safety of ketotifen vs vitamin E in individuals with NAFLD. The primary outcome was the change in hepatic steatosis, while the secondary outcomes included modifications in fibrosis-related indices and inflammatory biomarkers. In addition to other biochemical, anthropometric, and metabolic parameters. Methods: In this randomized study, 60 individuals with NAFLD were allocated in a 1:1 ratio into two groups. The vitamin E group was treated with vitamin E, and the ketotifen group received ketotifen for six months. Anthropometric parameters, liver steatosis and fibrosis, lipid profile, glycemic markers, liver enzymes, matrix metalloproteinase (MMP)-9, and tumor necrosis factor (TNF)-α were measured before and after 6 months. Results: Ketotifen treatment resulted in significant improvements in hepatic steatosis and disease activity compared with vitamin E, including lower steatosis and FibroScan-AST (FAST) score. Fibrosis severity was also reduced, with significant decreases in fibrosis score and fibrosis index (FIB-4) index, whereas Metabolic-Associated Steatosis Combined with Keratin-18 (MACK-3) score showed no significant between-group change. Glycemic outcomes improved significantly with ketotifen, including reductions in HOMA-IR, fasting blood glucose, and fasting insulin. Ketotifen also significantly reduced AST, TNF-α and MMP-9, and improved central adiposity measures (hip circumference, waist–stature ratio. No significant differences were observed for lipid profile, body weight, body mass index, or HbA1c. Ketotifen was generally well tolerated; drowsiness was the most common adverse event. Conclusion: Ketotifen exerts superior hepatoprotective, anti-inflammatory, antifibrotic, and insulin-sensitizing effects compared with vitamin E in NAFLD. These findings suggest that ketotifen may offer a promising adjunctive therapy for NAFLD. Clinical Trial Registration: NCT05616442.
- 1 April 2026
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 20, 1-23
Open AccessImmunomodulatory and Anti-Inflammatory Effects of Ketotifen Versus Vitamin E in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Pilot Study
Background: Non-alcoholic fatty liver disease (NAFLD) represents a prevalent, long-standing hepatic condition marked by the accumulation of fat in the liver and varying degrees of fibrotic changes. Ketotifen, a mast cell stabilizer, has been proposed to modulate inflammation and fibrogenesis, but clinical evidence is limited. Objective: To assess the effectiveness and safety of ketotifen vs vitamin E in individuals with NAFLD. The primary outcome was the change in hepatic steatosis, while the secondary outcomes included modifications in fibrosis-related indices and inflammatory biomarkers. In addition to other biochemical, anthropometric, and metabolic parameters. Methods: In this randomized study, 60 individuals with NAFLD were allocated in a 1:1 ratio into two groups. The vitamin E group was treated with vitamin E, and the ketotifen group received ketotifen for six months. Anthropometric parameters, liver steatosis and fibrosis, lipid profile, glycemic markers, liver enzymes, matrix metalloproteinase (MMP)-9, and tumor necrosis factor (TNF)-α were measured before and after 6 months. Results: Ketotifen treatment resulted in significant improvements in hepatic steatosis and disease activity compared with vitamin E, including lower steatosis and FibroScan-AST (FAST) score. Fibrosis severity was also reduced, with significant decreases in fibrosis score and fibrosis index (FIB-4) index, whereas Metabolic-Associated Steatosis Combined with Keratin-18 (MACK-3) score showed no significant between-group change. Glycemic outcomes improved significantly with ketotifen, including reductions in HOMA-IR, fasting blood glucose, and fasting insulin. Ketotifen also significantly reduced AST, TNF-α and MMP-9, and improved central adiposity measures (hip circumference, waist–stature ratio. No significant differences were observed for lipid profile, body weight, body mass index, or HbA1c. Ketotifen was generally well tolerated; drowsiness was the most common adverse event. Conclusion: Ketotifen exerts superior hepatoprotective, anti-inflammatory, antifibrotic, and insulin-sensitizing effects compared with vitamin E in NAFLD. These findings suggest that ketotifen may offer a promising adjunctive therapy for NAFLD. Clinical Trial Registration: NCT05616442.
- Open Access
Exploring Parental Hesitancy and Acceptance of HPV Vaccination in a Saudi Population
Background: Human papillomavirus (HPV) vaccination is a major concern and highly effective strategy for preventing cervical cancer and other related diseases. Despite the inclusion of the HPV vaccine in the Saudi national immunization program and recent school-based initiatives, vaccine uptake remains suboptimal, mainly due to the hesitancy of parents. Evidence regarding HPV vaccine hesitancy in the Aseer region of Saudi Arabia is limited. Objectives: This study aimed to assess the level of the HPV vaccine hesitancy, knowledge, attitude and barriers among parents in the Aseer region of Saudi Arabia using the World Health Organization (WHO) HPV Vaccine Hesitancy Scale (VAS). Methods: A cross-sectional study was conducted among parents residing in the Aseer region, Saudi Arabia. Data were collected using a structured questionnaire that included sociodemographic characteristics, knowledge, barriers and the validated nine-item WHO HPV Vaccine Hesitancy Scale. Data was expressed in numbers (%) for categorical variables and mean ± SD for continuous variables. Independent t-tests and one-way ANOVA were used for inferential statistics. Results: A total of 379 parents participated in the study. Overall, 49% of parents exhibited high HPV vaccine hesitancy. The most frequently reported barriers were safety concerns (82.6%), insufficient information (80.3%) and fear of side effects (79.4). Lower hesitancy scores were observed among parents aged ≥ 46 years than among those aged 18–25 years (p = 0.022), and respondents with postgraduate education were less hesitant than those with a high school education or less (p = 0.030). Parents whose children were fully vaccinated exhibited significantly lower hesitancy scores compared with those whose children were unvaccinated (p = 0.004). Conclusions: The HPV vaccine hesitancy among parents in the Aseer region is greatly influenced by the age of the parents, their educational level, and the child’s vaccination history. Higher hesitancy among younger parents, those with lower educational levels, and parents of unvaccinated children highlights priority groups for targeted interventions. Strengthening healthcare-provider recommendations and implementing culturally tailored, evidence-based communication strategies may improve HPV vaccine acceptance and support national cervical cancer prevention efforts in Saudi Arabia.
Open AccessExploring Parental Hesitancy and Acceptance of HPV Vaccination in a Saudi Population
Background: Human papillomavirus (HPV) vaccination is a major concern and highly effective strategy for preventing cervical cancer and other related diseases. Despite the inclusion of the HPV vaccine in the Saudi national immunization program and recent school-based initiatives, vaccine uptake remains suboptimal, mainly due to the hesitancy of parents. Evidence regarding HPV vaccine hesitancy in the Aseer region of Saudi Arabia is limited. Objectives: This study aimed to assess the level of the HPV vaccine hesitancy, knowledge, attitude and barriers among parents in the Aseer region of Saudi Arabia using the World Health Organization (WHO) HPV Vaccine Hesitancy Scale (VAS). Methods: A cross-sectional study was conducted among parents residing in the Aseer region, Saudi Arabia. Data were collected using a structured questionnaire that included sociodemographic characteristics, knowledge, barriers and the validated nine-item WHO HPV Vaccine Hesitancy Scale. Data was expressed in numbers (%) for categorical variables and mean ± SD for continuous variables. Independent t-tests and one-way ANOVA were used for inferential statistics. Results: A total of 379 parents participated in the study. Overall, 49% of parents exhibited high HPV vaccine hesitancy. The most frequently reported barriers were safety concerns (82.6%), insufficient information (80.3%) and fear of side effects (79.4). Lower hesitancy scores were observed among parents aged ≥ 46 years than among those aged 18–25 years (p = 0.022), and respondents with postgraduate education were less hesitant than those with a high school education or less (p = 0.030). Parents whose children were fully vaccinated exhibited significantly lower hesitancy scores compared with those whose children were unvaccinated (p = 0.004). Conclusions: The HPV vaccine hesitancy among parents in the Aseer region is greatly influenced by the age of the parents, their educational level, and the child’s vaccination history. Higher hesitancy among younger parents, those with lower educational levels, and parents of unvaccinated children highlights priority groups for targeted interventions. Strengthening healthcare-provider recommendations and implementing culturally tailored, evidence-based communication strategies may improve HPV vaccine acceptance and support national cervical cancer prevention efforts in Saudi Arabia.